Joyce Wong

Antibody Engineering Scientist at IgGenix

Joyce Wong has worked in the field of life sciences since 2005. Joyce began their career as a Ph.D. Candidate at the University of Alberta, where they solved the crystal structure of the TraM-sbmA protein-DNA complex and apo-N-terminal domain, studied cooperative TraM binding to sbmA by electrophoretic mobility shift assay, and characterized the binding of the TraD C-terminal peptide to the TraM C-terminal domain by x-ray crystallography and pulldown assays. In 2012, they moved to Stanford University, where they worked as a Basic Life Science Research Scientist and a Postdoctoral Fellow. In 2019, they were a Visiting Scholar at the University of California, Berkeley, where they studied Nipah virus cell entry proteins on a supported lipid bilayer and total internal reflection fluorescence microscopy platform. Currently, Joyce is an Antibody Engineering Scientist at IgGenix, Inc.

Joyce Wong obtained a B.Sc., Honors, Co-op in Biochemistry from The University of British Columbia between 2000 and 2005. Joyce then went on to obtain a Ph.D. in Biochemistry from the University of Alberta between 2005 and 2012.

Location

San Francisco, United States

Links

Previous companies


Org chart

No direct reports

Teams


Offices

This person is not in any offices


IgGenix

IgGenix is an early-stage, venture backed biotechnology company founded on breakthrough advances in Steve Quake’s laboratory at Stanford in collaboration with allergy clinician and researcher Kari Nadeau. They work on translating research discoveries into transformative therapies for individuals suffering from allergies.


Industries

Employees

11-50

Links